Minocycline safety and tolerability in Huntington disease.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 15304592.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Minocycline is an antibiotic with anti-inflammatory and antiapoptotic properties that prolongs survival in a transgenic Huntington disease (HD) mouse model. In a double-blind, randomized, placebo-controlled study of minocycline in 60 HD patients, the authors determined that over 8 weeks, minocycline at 100 and 200 mg/day was well tolerated and safe in HD patients. Tolerability and adverse event frequency were similar between treatment and placebo groups.
Medical subject headings
- Cysteine Proteinase Inhibitors
- Huntington Disease
- Minocycline